Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Investing.com - Stifel has maintained its Hold rating and $4.00 price target on Martin Midstream Partners (NASDAQ:MMLP) stock, according to a research note released Thursday. The midstream operator, with a market capitalization of $109.6 million and a FAIR financial health score according to InvestingPro, has maintained dividend payments for 23 consecutive years despite current profitability challenges.
The partnership reported adjusted EBITDA of $19.3 million, falling short of Stifel’s estimate of $25.5 million for the period.
Martin Midstream Partners posted negative distributable cash flow (DCF) of $3.4 million, compared to positive DCF of $2.4 million in the prior year. This result also fell below Stifel’s projection of $3.9 million.
The company announced a distribution per unit (DPU) of $0.005, which equates to $0.02 annually. This distribution aligned with Stifel’s expectations.
MMLP stock currently trades at $3.09 per share, representing approximately 23% potential upside to Stifel’s unchanged $4.00 price target.
In other recent news, Martin Midstream Partners reported a significant third-quarter net loss of $8.4 million, or -$0.21 per unit. This result was notably below analyst estimates, which anticipated a loss of only -$0.02 per unit. The underperformance was attributed to unexpected challenges in the company’s marine transportation and grease segments. Additionally, Martin Midstream Partners generated an adjusted EBITDA of $19.3 million for the quarter ending September 30, 2025, a decrease from $25.1 million in the same quarter of the previous year. The company has also decided to withdraw its full-year 2025 guidance due to ongoing demand softness affecting inland barge utilization. These developments come as the company navigates current market conditions and adjusts its strategies accordingly.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.